White coat hypertension can be defined as an elevated clinic blood pressure (BP) in association with normal ambulatory (A) or home (H) BP. However, to identify white-coat hypertension, the use of ABP monitoring is still limited by its cost and the discomfort that can generate while not all patients are candidate for HBP monitoring (i.e. anxious, incompliant and unreliable subjects). Aim of the present study was to assess whether repeated office blood pressure (ROBP) measurements were able to discriminate white-coat from sustained hypertension.
P-12 INTERACTION BETWEEN GLYCERYL TRINITRATE AND SILDENAFIL CITRATE (VIAGRA®) MAY LAST LESS THAN 4 HOURS
Sildenafil citrate (VIAGRA®) is a potent inhibitor of cGMP-dependent phosphodiesterase type 5 (PDE5) for the treatment of erectile dysfunction. The presence of PDE5 in the vasculature results in a pharmacodynamic interaction of sildenafil with nitric oxide donor drugs, such as glyceryl trinitrate (GTN). Thus, coadministration of nitrates and sildenafil within 24 hours of each other is contraindicated. The purpose of this study was to examine the duration of hemodynamic interaction between sildenafil and a nitrate. This was a double-blind, randomized, 2-way crossover study in 33 healthy male volunteers that measured the hemodynamic effects of sublingual GTN spray (0.4 mg) administered at multiple time points (1-48 hours) following an oral 100-mg dose of sildenafil or placebo. The effects of sildenafil plus GTN on sitting blood pressure (BP) were significantly greater than those of placebo plus GTN at 1 hour with no statistically significant interaction at other time points. Statistically significant differences in sitting heart rate seen at 1, 6, and 24 hours after sildenafil were small and not clinically meaningful. The degree of hemodynamic interaction corresponded with plasma sildenafil concentrations, which were maximal 1 hour after dosing. The overall incidence of treatment-related adverse events was low, with the highest incidence occurring at the 1-hour time point. In conclusion, during the 48-hour period following a 100-mg dose of sildenafil, concomitant GTN administration produced a significantly greater decrease in BP compared to administration with placebo, only at the 1-hour time point. Thus, in healthy volunteers, the hemodynamic interaction between sildenafil and nitrates lasted Ͻ4 hours.
Key Words: Sildenafil Citrate, Nitrates, Pharmacokinetics Low-grade inflammation and abnormal circadian blood pressure (BP) variation are related with augmented risk of cardiovascular complications. The aim of the study was to determine whether there is an association between the diurnal BP fluctuations and plasma concentrations of inflammatory markers, in essential hypertensive subjects.
P-13 ABSENCE OF RELATIONSHIP BETWEEN NON-DIPPING STATUS AND PLASMA LEVELS OF INFLAMMATORY MARKERS IN PATIENTS WITH UNTREATED ESSENTIAL HYPERTENSION
Towards this end, 62 newly diagnosed untreated patients with stage I to II essential hypertension (40 men, mean ageϭ48 years, office BPϭ144/95 mmHg) underwent ambulatory BP monitoring and were classified as dippers and non-dippers according to the diurnal variation of Ͼ10% between mean daytime and night-time systolic and diastolic BP. In all participants, plasma concentrations of C-reactive protein (CRP), serum amyloid A (SAA), macrophage chemoattractant protein-1 (MCP-1), tumor necrosis factor (TNF)-alpha and myeloperoxidase (MPO), were assessed.
In the entire population, body mass index was 28.2Ϯ4 kg/m 2 , left ventricular mass index was 99.5Ϯ23 g/m 2 , left atrial dimension was 3.58Ϯ0.5 cm, interventricular septum thickness was 1Ϯ0.13 cm, total cholesterol was 223.6Ϯ44 mg/dl, triglycerides were 136Ϯ38 mg/dl and low-density lipoprotein was 143Ϯ38 mg/dl. Regarding the inflammatory markers, CRP, SAA, TNF-alpha, MCP-1 and MPO levels were 2,29Ϯ0.2 mg/l, 6.05Ϯ0.6 mg/l, 7.3Ϯ0.7 pg/ml, 146.6Ϯ9 pg/ml and 0.48Ϯ0.02 U/ml, respectively. Non-dippers (18 subjects) and dippers (44 subjects) did not differ regarding plasma CRP, SAA, TNF-alpha, MCP-1 and MPO levels (pϭNS). Additionally, non-dippers had significantly greater 24-h systolic BP (by 8 mmHg, pϽ0.05), night-time systolic and diastolic BP (by 21 and 13 mmHg, respectively; pϽ0.05), ambulatory pulse pressure (by 5.1 mmHg, pϽ 0.05) and higher total cholesterol levels (by 26 mg/dl, 0Ͻ0.05), compared to dippers. Furthermore, there was no difference between the two study subgroups regarding left atrial dimension, left ventricular mass index and interventricular septum thickness (pϭNS).
In conclusion, the adverse cardiovascular outcome associated with non-dipping status, seems to be irrelevant to inflammatory processes, in 
